Triple
T19730320
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Lesath |
E473832
|
entity |
| Predicate | catalogIdentifier |
P8090
|
FINISHED |
| Object | CD−37 11636 |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: CD−37 11636 | Statement: [Lesath, catalogIdentifier, CD−37 11636]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: CD−37 11636 Context triple: [Lesath, catalogIdentifier, CD−37 11636]
-
A.
CD−59 4504
CD−59 4504 is a catalog designation for Beta Crucis, a bright blue giant star in the constellation Crux.
-
B.
CD−45 13193
CD−45 13193 is a catalog designation for Epsilon Telescopii, a bright giant star in the southern constellation Telescopium.
-
C.
CD21
CD21 is a complement receptor (CR2) found on B cells and follicular dendritic cells that plays a key role in B cell activation and the immune response.
-
D.
CD19
CD19 is a B-cell surface protein widely used as a key immunotherapy target in treatments for B-cell malignancies such as certain leukemias and lymphomas.
-
E.
CD38
CD38 is a cell surface glycoprotein with ectoenzyme and receptor functions, highly expressed on plasma cells and targeted in therapies for multiple myeloma and other hematologic malignancies.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: CD−37 11636 Target entity description: CD−37 11636 is a catalog designation for Lesath, a bright B-type star in the constellation Scorpius that forms part of the Scorpion’s stinger.
-
A.
CD−59 4504
CD−59 4504 is a catalog designation for Beta Crucis, a bright blue giant star in the constellation Crux.
-
B.
CD−45 13193
CD−45 13193 is a catalog designation for Epsilon Telescopii, a bright giant star in the southern constellation Telescopium.
-
C.
CD21
CD21 is a complement receptor (CR2) found on B cells and follicular dendritic cells that plays a key role in B cell activation and the immune response.
-
D.
CD19
CD19 is a B-cell surface protein widely used as a key immunotherapy target in treatments for B-cell malignancies such as certain leukemias and lymphomas.
-
E.
CD38
CD38 is a cell surface glycoprotein with ectoenzyme and receptor functions, highly expressed on plasma cells and targeted in therapies for multiple myeloma and other hematologic malignancies.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8e517ebd48190979ee76723bcfadf |
completed | April 10, 2026, 11:55 a.m. |
| NER | Named-entity recognition | batch_69e649fbeaf081909e9356229eaf84dd |
completed | April 20, 2026, 3:45 p.m. |
Created at: April 10, 2026, 1:47 p.m.